Read more: https://www.businessinsider.com/trump-t ... reddit.comDonald Trump said he'd put in place 25% tariffs on Mexican and Canadian imports upon taking office.
This would push up prices for US-assembled cars by an average of $2,100, according to Wells Fargo.
Mexico's president said her country would retaliate in kind to tariffs, impacting joint ventures.
Read more: https://www.cnbc.com/2024/12/23/honda-a ... talks.html
Japanese automakers Nissan and Honda on Monday announced they had entered into official talks to merge and create the world’s third-largest automaker by sales.
In a press conference on Monday, Honda CEO Toshihiro Mibe said the companies needed greater scale to compete in the development of new technologies in electric vehicles and intelligent driving. A business integration would give the companies an “edge that will not be possible under the current collaboration framework,” Mibe said, according to a translation.
The deal would aim to share intelligence and resources and deliver economies of scale and synergies while protecting both brands, he said.
A holding company would be formed as the parent company of both Honda and Nissan, listed on the Tokyo Stock Exchange. The larger Honda will nominate most of the integrated entity’s board members. The merged group has the potential to deliver revenue of 30 trillion yen ($191.4 billion) and operating profit of over 3 trillion yen, he said.
Read more: https://www.reuters.com/business/health ... 024-12-31/
NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer (PFE.N) COVID-19 treatment Paxlovid, Bristol Myers Squibb's (BMY.N), cancer cell therapies and vaccines from France's Sanofi (SASY.PA) at the start of 2025, according to data analyzed by healthcare research firm 3 Axis Advisors.
Nearly all of the drug price increases are below 10% - most well below. The median price increase of the drugs being hiked Jan. 1 is 4.5%, which is in line with the median for all price increases last year. The increases are to list prices, which do not include rebates to pharmacy benefit managers and other discounts.
Larger drug price increases were once far more common in the U.S. but in recent years drugmakers have scaled them back after price hikes drew sharp criticism in the middle of the last decade.
"Drugmakers don't have much real estate any longer to increase prices over time, which means taking greater liberties on launch prices is really the only option they have in the face of expanded penalties for year-over-year price increases," 3 Axis President Antonio Ciaccia said.
https://www.cbsnews.com/news/vivek-rama ... part-doge/Vivek Ramaswamy, President-elect Donald Trump's choice to co-lead the Department of Government Efficiency (DOGE) with entrepreneur Elon Musk, is expected to soon step away from the task force, CBS News has learned. Ramaswamy intends to announce a campaign for Ohio governor as soon as the end of January, multiple sources confirmed to CBS News.
Ramaswamy, 39, had no comment.
People close to Musk have privately undercut Ramaswamy for weeks, frustrated with his lack of participation in the heavy lifting, according to sources familiar with the internal dynamics. There has been friction between the incoming rank and file DOGE staff and Ramaswamy, the sources said, and Ramaswamy has been subtly encouraged to exit.
"Vivek has worn out his welcome," one person close to Trump said.
Ramaswamy recently met with the Ohio's sitting governor, Mike DeWine, about the state's Senate seat left vacant by Vice President-elect JD Vance. But on Friday, DeWine announced he is appointing his lieutenant governor to the post.
Read more: https://www.nbcnews.com/politics/electi ... rcna190018
Ken Martin, the longtime leader of the state Democratic Party organization in Minnesota, will be the new Democratic National Committee chair after winning Saturday’s election, as his party looks to turn the page and recover from a dismal 2024.
Martin had been the frontrunner from the beginning of the race, leveraging his relationships with the more than 400 voting members of the DNC that he forged over more than a decade of work inside the institutional Democratic Party.
The race hinged more on the candidates’ organizing and fundraising resumes instead of becoming a battle for the ideological soul of the party, as it did in 2017, after President Donald Trump’s previous election win. Martin was the more experienced hand with deep party relationships, Wisconsin Democratic Party Chairman Ben Wikler had been at the center of some of Democrats’ highest-profile races in recent years, and former Maryland Gov. Martin O’Malley had unique electoral and government experience.
Now, Martin will be tasked with helping to pull Democrats out of the hole where they ended 2024, a devastating election cycle that left them without any of the levers of power in Washington. But while Martin will help to lead the party forward, Democrats aren’t necessarily looking to him to be the party’s pre-eminent leader.
